STOCK TITAN

Inogen Revises Presentation Time at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Inogen, Inc. (NASDAQ: INGN) announced that its presentation at the 40th Annual J.P. Morgan Healthcare Conference has been rescheduled to a virtual format. President and CEO Nabil Shabshab will present on January 12, 2022, at 10:30 a.m. ET. Interested investors can access the live audio webcast through the Investor Relations section on the Inogen website. A replay will be available shortly after the live event for 90 days. Inogen specializes in developing and marketing portable oxygen concentrators for patients with chronic respiratory conditions.

Positive
  • Rescheduled presentation at a prominent healthcare conference increases visibility.
  • CEO Nabil Shabshab's participation may boost investor confidence.
Negative
  • None.

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s presentation at the 40th Annual J.P. Morgan Healthcare Conference has been moved due to the conference moving into a virtual format.

Inogen’s President and CEO, Nabil Shabshab, is now scheduled to present on Wednesday, January 12th, 2022 at 10:30 a.m. ET. Interested parties can access the live audio webcast from the News / Events section of the Investor Relations page on the Inogen website at www.inogen.com. A webcast replay will be available approximately one hour after the conclusion of the live presentation and will remain available for 90 days.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

Investor and Media Contacts

Bryan Locke, Mike DeGraff, Gabriella Coffey

Inogen-SVC@sardverb.com

(312) 895-4700

Source: Inogen, Inc.

FAQ

When is Inogen's presentation at the J.P. Morgan Healthcare Conference?

Inogen's presentation is scheduled for January 12, 2022, at 10:30 a.m. ET.

How can I access Inogen's presentation?

The presentation can be accessed via a live audio webcast from the Investor Relations page on Inogen's website.

What company does the stock symbol INGN represent?

The stock symbol INGN represents Inogen, Inc.

What products does Inogen specialize in?

Inogen specializes in innovative portable oxygen concentrators for homecare use.

Inogen Inc

NASDAQ:INGN

INGN Rankings

INGN Latest News

INGN Stock Data

197.93M
23.36M
1.84%
89.67%
3.13%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
GOLETA